| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/07/2013 | US20130059923 Therapeutic Foam |
| 03/07/2013 | US20130059842 Manufacturing of quick release pharmaceutical compositons of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 03/07/2013 | US20130059828 Pharmaceutical composition |
| 03/07/2013 | US20130059410 Solution-Based Fabrication of Photovoltaic Cell |
| 03/07/2013 | US20130059382 Biomedical materials for tissue engineering |
| 03/07/2013 | US20130059062 Device For The Manufacture Of A Dosage Form With A Hole And Method Of Manufacture |
| 03/07/2013 | US20130059010 Alcohol-resistant oral pharmaceutical form |
| 03/07/2013 | US20130059009 Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers |
| 03/07/2013 | US20130059007 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes |
| 03/07/2013 | US20130059006 3-dimensional cardiac fibroblast derived extracellular matrix |
| 03/07/2013 | US20130059005 Bupropion hydrobromide polymorphs |
| 03/07/2013 | US20130059004 Oral drug delivery system |
| 03/07/2013 | US20130059003 Sustained release donepezil formulations |
| 03/07/2013 | US20130059002 Pharmaceutical compositions comprising a combination of metformin and sitagliptin |
| 03/07/2013 | US20130059001 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
| 03/07/2013 | US20130059000 Oral delivery for hemoglobin based oxygen carriers |
| 03/07/2013 | US20130058999 Pharmaceutical compositions for oral administration of insulin peptides |
| 03/07/2013 | US20130058998 Encapsulated n-acetylmannosamine or n-acetylneuraminic acid to increase sialylation |
| 03/07/2013 | US20130058997 Vaccine composition containing synthetic adjuvant |
| 03/07/2013 | US20130058996 LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF |
| 03/07/2013 | US20130058995 Composition and method for weight reduction |
| 03/07/2013 | US20130058994 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058992 Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and identification of agents which have efficacy for the treatment of cancer |
| 03/07/2013 | US20130058991 Matricryptic ecm peptides for tissue reconstruction |
| 03/07/2013 | US20130058989 Capsule having broad color spectrum |
| 03/07/2013 | US20130058987 Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof |
| 03/07/2013 | US20130058986 Solid dosage forms comprising an enteric coating with accelerated drug release |
| 03/07/2013 | US20130058985 Spray-Pumpable Composition Suitable for Topical Skin Application |
| 03/07/2013 | US20130058984 Single-walled carbon nanotube/bioactive substance complexes and methods related thereto |
| 03/07/2013 | US20130058983 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 03/07/2013 | US20130058982 Method of treating Alzheimer's disease |
| 03/07/2013 | US20130058981 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| 03/07/2013 | US20130058875 Capsule having broad color spectrum |
| 03/07/2013 | US20130058870 3d nanocrystals and manufacturing methods |
| 03/07/2013 | US20130058869 Prevention And Treatment Of Amyloidogenic Disease |
| 03/07/2013 | DE112009002721T5 Antiemetisches Pflaster Antiemetic patch |
| 03/07/2013 | DE102011112374A1 Temporarily tightening the human skin, preferably on the leg to reduce spider veins comprises applying a short-term cold stimulus on the skin, where the cold stimulus temporarily lowers the temperature of the skin and tightens the skin |
| 03/07/2013 | CA2847328A1 Oral formulations containing hyaluronic acid for sustained drug release |
| 03/07/2013 | CA2847218A1 Formulations and dosage forms of oxidized phospholipids |
| 03/07/2013 | CA2846858A1 Methods for effectively and rapidly desensitizing allergic patients |
| 03/07/2013 | CA2846446A1 Multi-layered release formulation |
| 03/07/2013 | CA2846384A1 Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 03/07/2013 | CA2846043A1 Pegylated liposomes for delivery of immunogen-encoding rna |
| 03/07/2013 | CA2845784A1 Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same |
| 03/07/2013 | CA2845585A1 Decitabine derivative formulations |
| 03/07/2013 | CA2844510A1 Method for the preparation of a heat stable oxygen carrier-containing composition facilitating beta-beta cross-linking |
| 03/07/2013 | CA2844288A1 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride |
| 03/06/2013 | EP2565157A2 Nitric oxide generation |
| 03/06/2013 | EP2564900A1 C-19 steroids for therapeutic uses |
| 03/06/2013 | EP2564875A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging of digestive tract |
| 03/06/2013 | EP2564873A1 Skin irritation suppressant and transdermal preparation |
| 03/06/2013 | EP2564861A1 Pharmaceutical formula for treating mastitis in mammals |
| 03/06/2013 | EP2564848A1 Transdermally absorbable donepezil-containing preparation |
| 03/06/2013 | EP2564847A1 Pharmaceutical composition for improving solubility of prasugrel and its preparation method |
| 03/06/2013 | EP2564845A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases |
| 03/06/2013 | EP2564840A1 Compositions for the symptomatic relief of stomach pain or gastro-oesophageal reflux |
| 03/06/2013 | EP2564839A2 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| 03/06/2013 | EP2564838A1 Enteric tablet |
| 03/06/2013 | EP2564837A1 Enteric tablet |
| 03/06/2013 | EP2564836A1 Controlled release lamotrigine formulations |
| 03/06/2013 | EP2564835A1 Fast-dissolving solid pharmaceutical form for treating bacterial infections |
| 03/06/2013 | EP2564834A2 Compounds for Proteasome Enzyme Inhibition |
| 03/06/2013 | EP2564833A1 Photostabilized pharmaceutical composition |
| 03/06/2013 | EP2564832A1 Solid dosage form of HIV protease inhibitors |
| 03/06/2013 | EP2564831A1 Dermatological emulsion and method for preparing same |
| 03/06/2013 | EP2564789A1 Adhesive patch and adhesive preparation |
| 03/06/2013 | EP2563809A2 Stable aqueous mia/cd-rap formulations |
| 03/06/2013 | EP2563452A2 Composite microneedle array including nanostructures thereon |
| 03/06/2013 | EP2563450A2 Device for delivery of rheumatoid arthritis medication |
| 03/06/2013 | EP2563426A2 High shear application in medical therapy |
| 03/06/2013 | EP2563371A1 Anti-bacterial applications of poly -n-acetylglucosamine nanofibers |
| 03/06/2013 | EP2563366A2 Uses of phospholipid conjugates of synthetic tlr7 agonists |
| 03/06/2013 | EP2563350A2 Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| 03/06/2013 | EP2563349A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof |
| 03/06/2013 | EP2563347A2 Propynylaminoindan transdermal compositions |
| 03/06/2013 | EP2563346A1 Solid oral dosage forms comprising tadalafil |
| 03/06/2013 | EP2563345A2 Layered drug delivery device |
| 03/06/2013 | EP2563344A1 Oral dosage forms |
| 03/06/2013 | EP2563343A1 Apparatus and kit for encapsulating at least one compound for therapeutic and/or diagnostic use in erythrocytes |
| 03/06/2013 | EP2563342A1 Indigestible polymer: starch acetate -based film coatings for colon targeting |
| 03/06/2013 | EP2563341A1 Pharmaceutical compositions inducing synergistic effect |
| 03/06/2013 | EP2563340A2 Water soluble pharmaceutical composition |
| 03/06/2013 | EP2563339A1 Controlled release pharmaceutical compositions of brivaracetam |
| 03/06/2013 | EP2563338A2 High shear application in drug delivery |
| 03/06/2013 | EP2563337A1 Carrier and targeting system comprising a siosomal composition for intracellular delivery and targeting of active substance |
| 03/06/2013 | EP2563336A2 Aerosol foams comprising clindamycin phosphate |
| 03/06/2013 | EP2563335A2 Low-oil pharmaceutical emulsion compositions comprising progestogen |
| 03/06/2013 | EP2563334A2 Pharmaceutical emulsion compositions comprising progestogen |
| 03/06/2013 | EP2563333A2 Selected plant extracts for the treatment of inflammatory diseases |
| 03/06/2013 | EP2563332A2 Clay compositions |
| 03/06/2013 | EP2563331A2 Pharmaceutical powder compositions |
| 03/06/2013 | EP2563330A2 Nicotine-containing pharmaceutical compositions |
| 03/06/2013 | EP2563329A2 Orally disintegrating tablet containing acarbose |
| 03/06/2013 | EP2563304A1 Methods and compositions for reversibly reducing the aural sensitivity of humans and animals |
| 03/06/2013 | EP2563164A1 Nanoemulsion including sucrose fatty acid ester |
| 03/06/2013 | EP2563160A1 Novel coating system |
| 03/06/2013 | EP2563157A2 Novel ruminant feed |
| 03/06/2013 | EP2563119A1 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 03/06/2013 | EP1792927B1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |